Login / Signup

Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study.

Haruna MatsuzakiMasakazu HatanoMiko IwataShigeki Yamada
Published in: Neuropsychiatric disease and treatment (2021)
The low continuation rate of asenapine in real-world data may be related to specific factors such as bitter taste and burden of the dosing method.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • bipolar disorder
  • prognostic factors
  • electronic health record
  • big data
  • machine learning
  • patient reported outcomes
  • drug induced